Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, especially for cancers where remedy selections remain limited. Make use of the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Check https://financefeeds.com/bullish-group-appoints-chris-tyrer-as-president-of-bullish-exchange/